GlaxoSmithKline has fired its former research boss Moncef Slaoui from the board of Galvani Bioelectronics, a company it majority owns, after an internal investigation found he sexually harassed a ...

Former GSK CEO Sir Andrew Witty, and his former drug development chief, Moncef Slaoui have both lined up new jobs as life science investors. The announcements yesterday are part of a growing trend ...

(Disclosure: The scientist who led that operation, Moncef Slaoui, is a friend.) That’s even without taking into account the surge. Or the Centers for Disease Control and Prevention ...

Moncef Slaoui, GSK's Chairman of Global Vaccines, says in a statement announcing the deal: "This agreement with Verily to establish Galvani Bioelectronics signals a crucial step forward in GSK's ...

Moncef Slaoui told CBS News that Americans could ... Getty Images Dr Slaoui, former vaccine chief at GlaxoSmithKline, was appointed by President Trump to lead the US efforts to speed up ...

As part of the agreement, GSK, Sanofi, and CSL will produce extra bulk vaccine components tailored to the circulating strains of avian influenza. Also Read: Medicare Drug Price Negotiation Program ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50. The company’s shares closed yesterday at p1,497. ...

"I do think it is appropriate to set the threshold of safety follow-up," Moncef Slaoui, the chief advisor ... as a pharmaceutical executive at GlaxoSmithKline. While Pfizer has said it could ...

Sept 11 (Reuters) - British drugmaker GSK (GSK.L), opens new tab said on Wednesday its experimental herpes simplex virus (HSV) vaccine candidate failed to meet the main goal of a mid-stage trial ...

By 31 December, fewer than three million had received one. Moncef Slaoui, who had been leading the government's vaccine rollout plan, said at the time: "We know that it should be better ...

Wolff Olins has created the new brand identity for global healthcare company GSK (formerly GlaxoSmithKline), aiming to better express its focus on innovation. The agency was brought on board around 18 ...